The PulseRider® is specifically designed to resolve the shortcomings of current endovascular devices by preserving luminal patency and hemodynamic flow through the parent vessel bifurcation, while minimizing exposed metal in order to encourage early endothelialization while securely retaining embolic agents within the aneurysm sac.

Slide 1
Feature Image 1

The PulseRider®

The PulseRider® has an open cell frame. The unique frame configuration opens to conform to the vessel walls. The PulseRider is specifically designed to resolve the shortcomings of current endovascular devices.

Feature Image 2

Platform Technology

Pulsar Vascular is pursuing additional products that leverage the core technology and advantages of the PulseRider® platform leaving little to no metal structure in the parent artery.

Feature Image 3

A New Treatment Option

The PulseRider® is a self expanding nitinol implant designed for the treatment of complex aneurysms. This new device provides an endovascular option to patients and physicians previously not available. The PulseRider acts as a neck bridge for wide neck aneurysms arising at or near a vessel bifurcation.

Feature Image 4

Codman Neuro Announces Acquisition Of Pulsar Vascular

Codman Neuro today announced the acquisition of Pulsar Vascular Inc., a privately held company based in Los Gatos, California with breakthrough platform technology for the neurovascular treatment of complex aneurysms. DePuy Synthes Products, Inc., an affiliate of Codman Neuro, is the acquiring entity. For Codman Neuro, a global market leader in neurovascular and neurosurgery, this acquisition marks the latest expansion of its neurovascular portfolio and will complement a comprehensive portfolio of products for hemorrhagic and ischemic stroke.